Cancer
Scientists at Austin Hospital target cancer
Published in Surgery Litigation and Law Weekly, August 24th, 2007
"The primary objective was to investigate safety and tolerability by determining dose-limiting toxicity (DLT). The secondary objectives were to identify a dose response for various biomarkers in the peripheral blood, estimate the minimum biologically effective dose, determine the pharmacokinetics of IL-21, determine if anti-IL-21 antibodies were induced during therapy,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
More Articles from Surgery Litigation and Law Weekly
- Amyotrophic Lateral Sclerosis
New findings from Columbia University in the area of amyotrophic lateral sclerosis published - Biotechnology Business
Genzyme Announces Settlement of Lawsuit Concerning Consolidation of Tracking Stocks - Cancer
OTN and Onmark Selected by Georgia Society of Clinical Oncology (GASCO) to Provide Oncology Services to Its Members - Covidien Ltd.
Covidien Reports Third-Quarter Results - Financials
Hillenbrand Industries Reports Third Quarter Revenues of $494.1 Million and Earnings From Continuing Operations of $0.57 Per Fully Diluted Share - Health Insurance
Consumer Reports Health Insurance Survey Reveals 1 in 4 People Insured but Not Adequately Covered - More from this issue of Surgery Litigation and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
